| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAZ | Common Stock | Options Exercise | +258K | +217.57% | 377K | Mar 13, 2025 | Direct | F1, F2 | ||
| transaction | LAZ | Common Stock | Disposed to Issuer | -$3.49M | -77.4K | -20.55% | $45.09 | 299K | Mar 13, 2025 | Direct | F2, F3, F4 |
| transaction | LAZ | Common Stock | Sale | -$1.22M | -27.2K | -9.09% | $44.87 | 272K | Mar 14, 2025 | Direct | F2, F5, F6 |
| transaction | LAZ | Common Stock | Sale | -$1.7M | -37.3K | -13.72% | $45.51 | 235K | Mar 14, 2025 | Direct | F2, F5, F7 |
| transaction | LAZ | Common Stock | Sale | -$1.73M | -38.2K | -16.26% | $45.31 | 197K | Mar 17, 2025 | Direct | F2, F5, F8 |
| transaction | LAZ | Common Stock | Sale | -$1.21M | -26.4K | -13.4% | $45.91 | 170K | Mar 17, 2025 | Direct | F2, F5, F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAZ | Performance-based Restricted Participation Units | Options Exercise | -258K | -100% | 0 | Mar 13, 2025 | Common Stock | 258K | Direct | F1, F10, F11, F12 | |||
| transaction | LAZ | Restricted Participation Units | Award | +168K | +121.59% | 307K | Mar 14, 2025 | Common Stock | 168K | Direct | F12, F13, F14 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Shares of Common Stock were acquired upon the exchange of the Performance-based Restricted Participation Units ("PRPUs") referenced in Footnote (10). |
| F2 | Amount excludes 63,666 restricted stock units directly or indirectly beneficially owned by the Reporting Person. |
| F3 | Represents shares of Common Stock sold to the Company to cover estimated taxes arising from the exchange of PRPUs referenced in Footnote (10). |
| F4 | Represents the average of the high and low price of Common Stock on the New York Stock Exchange on the date of the exchange of the PRPUs referenced in Footnote (10). |
| F5 | This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 13, 2024. Sales of shares pursuant to the plan are intended to cover estimated taxes and other personal expenditures. |
| F6 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $44.31 to $45.31 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F7 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 14, 2025 in trades with average execution prices ranging from $45.32 to $45.87 inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F8 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $44.80 to $45.80, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F9 | The price reported in Column 4 is the weighted average price. The shares were sold in multiple transactions that were executed on March 17, 2025 in trades with average execution prices ranging from $45.81 to $46.11, inclusive. The Reporting Person undertakes to provide the issuer, any security holder of the issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the price ranges set forth in this report. |
| F10 | Represents a prior grant of PRPUs awarded with respect to compensation for 2021 of which performance and other conditions have been satisfied. The grant at target was reflected in the Company's proxy statement for the relevant year. |
| F11 | Each PRPU (the performance and other conditions of which have been satisfied) represents an interest in Lazard Group LLC that may be exchanged for one share of Common Stock. |
| F12 | Amount excludes a prior grant of 1,250,000 Stock Price Performance-based Restricted Participation Units, which was reflected in the Company's proxy statement for the relevant year. |
| F13 | These Restricted Participation Units ("RPUs") will vest on or around March 15, 2027. |
| F14 | Each RPU represents an interest in Lazard Group LLC that has satisfied its minimum value condition and that may be exchanged for one share of Common Stock. |